Precipio signs distribution agreement for iv-cell® and hemescreen® in japan

New haven, conn., jan. 17, 2024 (globe newswire) -- specialty cancer diagnostics company precipio, inc. (nasdaq: prpo) announces it has entered into an agreement with a japanese distributor for the sales and distribution of its products into the japanese market.

PRPO Ratings Summary

PRPO Quant Ranking